214 related articles for article (PubMed ID: 8864918)
1. The role of MT2 and anti-bcl-2 protein antibodies in the differentiation of benign from malignant cutaneous infiltrates of B-lymphocytes with germinal center formation.
Chimenti S; Cerroni L; Zenahlik P; Peris K; Kerl H
J Cutan Pathol; 1996 Aug; 23(4):319-22. PubMed ID: 8864918
[TBL] [Abstract][Full Text] [Related]
2. [Cutaneous B cell processes with nodular pattern].
Chirife AM; Bilbao ER; Giménez L; Marino L
Medicina (B Aires); 2006; 66(4):307-12. PubMed ID: 16977965
[TBL] [Abstract][Full Text] [Related]
3. TOX expression in cutaneous B-cell lymphomas.
Schrader AM; Jansen PM; Willemze R
Arch Dermatol Res; 2016 Aug; 308(6):423-7. PubMed ID: 27180090
[TBL] [Abstract][Full Text] [Related]
4. Cutaneous b-cell lymphomas of follicular and marginal zone types: use of Bcl-6, CD10, Bcl-2, and CD21 in differential diagnosis and classification.
de Leval L; Harris NL; Longtine J; Ferry JA; Duncan LM
Am J Surg Pathol; 2001 Jun; 25(6):732-41. PubMed ID: 11395550
[TBL] [Abstract][Full Text] [Related]
5. Immunoreactivity for bcl-2 protein in cutaneous lymphomas and lymphoid hyperplasias.
Triscott JA; Ritter JH; Swanson PE; Wick MR
J Cutan Pathol; 1995 Feb; 22(1):2-10. PubMed ID: 7751474
[TBL] [Abstract][Full Text] [Related]
6. Bcl-2 oncoprotein is widespread in lymphoid tissue and lymphomas but its differential expression in benign versus malignant follicles and monocytoid B-cell proliferations is of diagnostic value.
Wang T; Lasota J; Hanau CA; Miettinen M
APMIS; 1995 Sep; 103(9):655-62. PubMed ID: 7488387
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of B-cell clonality using the BIOMED-2 PCR method effectively distinguishes cutaneous B-cell lymphoma from benign lymphoid infiltrates.
Morales AV; Arber DA; Seo K; Kohler S; Kim YH; Sundram UN
Am J Dermatopathol; 2008 Oct; 30(5):425-30. PubMed ID: 18806482
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic criteria of primary cutaneous B-cell lymphomas and pseudolymphomas.
Kerl H; Fink-Puches R; Cerroni L
Keio J Med; 2001 Dec; 50(4):269-73. PubMed ID: 11806505
[TBL] [Abstract][Full Text] [Related]
9. A specific monoclonal antibody (PG-B6) detects expression of the BCL-6 protein in germinal center B cells.
Flenghi L; Ye BH; Fizzotti M; Bigerna B; Cattoretti G; Venturi S; Pacini R; Pileri S; Lo Coco F; Pescarmona E
Am J Pathol; 1995 Aug; 147(2):405-11. PubMed ID: 7639334
[TBL] [Abstract][Full Text] [Related]
10. Differential diagnosis of cutaneous infiltrates of B lymphocytes with follicular growth pattern.
Leinweber B; Colli C; Chott A; Kerl H; Cerroni L
Am J Dermatopathol; 2004 Feb; 26(1):4-13. PubMed ID: 14726817
[TBL] [Abstract][Full Text] [Related]
11. Primary cutaneous follicle center cell lymphomas and large B cell lymphomas of the leg descend from germinal center cells. A single cell polymerase chain reaction analysis.
Gellrich S; Rutz S; Golembowski S; Jacobs C; von Zimmermann M; Lorenz P; Audring H; Muche M; Sterry W; Jahn S
J Invest Dermatol; 2001 Dec; 117(6):1512-20. PubMed ID: 11886516
[TBL] [Abstract][Full Text] [Related]
12. Primary cutaneous follicle center cell lymphoma with follicular growth pattern.
Cerroni L; Arzberger E; Pütz B; Höfler G; Metze D; Sander CA; Rose C; Wolf P; Rütten A; McNiff JM; Kerl H
Blood; 2000 Jun; 95(12):3922-8. PubMed ID: 10845929
[TBL] [Abstract][Full Text] [Related]
13. Bcl-2, Bcl-6 and CD10 expression in cutaneous B-cell lymphoma: further support for a follicle centre cell origin and differential diagnostic significance.
Hoefnagel JJ; Vermeer MH; Jansen PM; Fleuren GJ; Meijer CJ; Willemze R
Br J Dermatol; 2003 Dec; 149(6):1183-91. PubMed ID: 14674895
[TBL] [Abstract][Full Text] [Related]
14. Absence of the t(14;18) chromosomal translocation in primary cutaneous B-cell lymphoma.
Child FJ; Russell-Jones R; Woolford AJ; Calonje E; Photiou A; Orchard G; Whittaker SJ
Br J Dermatol; 2001 Apr; 144(4):735-44. PubMed ID: 11298531
[TBL] [Abstract][Full Text] [Related]
15. Primary cutaneous marginal zone B-cell lymphoma: a recently described entity of low-grade malignant cutaneous B-cell lymphoma.
Cerroni L; Signoretti S; Höfler G; Annessi G; Pütz B; Lackinger E; Metze D; Giannetti A; Kerl H
Am J Surg Pathol; 1997 Nov; 21(11):1307-15. PubMed ID: 9351568
[TBL] [Abstract][Full Text] [Related]
16. bcl-2 protein expression and correlation with the interchromosomal 14;18 translocation in cutaneous lymphomas and pseudolymphomas.
Cerroni L; Volkenandt M; Rieger E; Soyer HP; Kerl H
J Invest Dermatol; 1994 Feb; 102(2):231-5. PubMed ID: 8106752
[TBL] [Abstract][Full Text] [Related]
17. Immunophenotyping of cutaneous lymphoid infiltrates in frozen and paraffin-embedded tissue sections: a comparative study.
Cerroni L; Smolle J; Soyer HP; Martinez Aparicio A; Kerl H
J Am Acad Dermatol; 1990 Mar; 22(3):405-13. PubMed ID: 2179300
[TBL] [Abstract][Full Text] [Related]
18. Primary Cutaneous Follicle Center Lymphoma.
Skala SL; Hristov B; Hristov AC
Arch Pathol Lab Med; 2018 Nov; 142(11):1313-1321. PubMed ID: 30407851
[TBL] [Abstract][Full Text] [Related]
19. Paraffin section immunohistochemistry as an adjunct to morphologic analysis in the diagnosis of cutaneous lymphoid infiltrates.
Ritter JH; Adesokan PN; Fitzgibbon JF; Wick MR
J Cutan Pathol; 1994 Dec; 21(6):481-93. PubMed ID: 7699114
[TBL] [Abstract][Full Text] [Related]
20. Aberrant MT2 positivity distinguishes follicular lymphoma from reactive follicular hyperplasia in B5- and formalin-fixed paraffin sections.
Browne G; Tobin B; Carney DN; Dervan PA
Am J Clin Pathol; 1991 Jul; 96(1):90-4. PubMed ID: 1712546
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
